Human induced pluripotent stem cell–derived cardiomyocytes as an in vitro model for coxsackievirus B3–induced myocarditis and antiviral drug screening platform

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · see citing works

Antiviral Actions of Interferons

Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · see citing works

Sudden Deaths in Young Competitive Athletes

Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,075 · see citing works

Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling

Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717 · see citing works

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

Claycomb, W. C., Lanson, N. A., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., & Izzo, N. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2979 · Cited by 1,546 · see citing works

Myocarditis

Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,317 · see citing works

Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes

Tohyama, S., Hattori, F., Sano, M., Hishiki, T., Nagahata, Y., Matsuura, T., Hashimoto, H., Suzuki, T., Yamashita, H., Satoh, Y., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.09.013 · Cited by 1,045 · see citing works

Myocarditis

Feldman, A. M., & McNamara, D. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 962 · see citing works

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 823 · see citing works

Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells

Lundy, S. D., Zhu, W.-Z., Regnier, M., & Laflamme, M. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0490 · Cited by 738 · see citing works

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

Cohen, C. J., Shieh, J. T. C., Pickles, R. J., Okegawa, T., Hsieh, J., & Bergelson, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261452898 · Cited by 702 · see citing works

Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy

Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696 · see citing works

Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming

Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670 · see citing works

DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY

Bowles, N. E., Olsen, E. G. J., Richardson, P. J., & ARCHARD, L. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91837-4 · Cited by 601 · see citing works

Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Badorff, C., Lee, G.-H., Lamphear, B. J., Martone, M. E., Campbell, K. P., Rhoads, R. E., & Knowlton, K. U. (1999) · Nature Medicine · doi:10.1038/6543 · Cited by 574 · see citing works

Active Myocarditis in the Spectrum of Acute Dilated Cardiomyopathies

DEC, G. W., Palacios, I. F., Fallon, J. T., Aretz, H. T., Mills, J. L., Lee, D. C.-S., & Johnson, R. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121404 · Cited by 562 · see citing works

Diagnosis of Myocarditis

Baughman, K. L. (2006) · Circulation · doi:10.1161/circulationaha.105.589663 · Cited by 543 · see citing works

Interferon-β Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction

Kühl, U., Pauschinger, M., Schwimmbeck, P. L., Seeberg, B., Lober, C., Noutsias, M., Poller, W. C., & Schultheiß, H. (2003) · Circulation · doi:10.1161/01.cir.0000072766.67150.51 · Cited by 499 · see citing works

Sudden unexpected death in persons <40 years of age

Drory, Y., Turetz, Y., Hiss, Y., Lev, B. I., Fisman, E. Z., Pines, A., & Kramer, M. R. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90251-f · Cited by 422 · see citing works

Molecular Mechanisms of Interferon Resistance Mediated by Viral-Directed Inhibition of PKR, the Interferon-Induced Protein Kinase

Gale, M., & Katze, M. G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00165-4 · Cited by 388 · see citing works

Cardiac fatty acid uptake and transport in health and disease

Vusse, G. J. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00263-1 · Cited by 318 · see citing works

The Coxsackievirus B 3Cpro Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling

Mukherjee, A., Morosky, S. A., Delorme‐Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., & Coyne, C. B. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001311 · Cited by 306 · see citing works

Cultured adult cardiac myocytes Future applications, culture methods, morphological and electrophysiological properties

Mitcheson, J. S. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00128-x · Cited by 251 · see citing works

Drug-induced long QT and torsade de pointes: recent advances

Kannankeril, P. J., & Roden, D. M. (2006) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 230 · see citing works

Human Stem Cells for Modeling Heart Disease and for Drug Discovery

Matsa, E., Burridge, P. W., & Wu, J. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008921 · Cited by 210 · see citing works

Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins α v β 3 and α v β 5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy

Noutsias, M., Fechner, H., de Jonge, H. W., Wang, X., Dekkers, D. H. W., Houtsmuller, A. B., Pauschinger, M., Bergelson, J. M., Warraich, R. S., Yacoub, M. H., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.275 · Cited by 203 · see citing works

GBF1, a Guanine Nucleotide Exchange Factor for Arf, Is Crucial for Coxsackievirus B3 RNA Replication

Lanke, K. H. W., van der Schaar, H. M., Belov, G. A., Feng, Q., Duijsings, D., Jackson, C. L., Ehrenfeld, E., & van Kuppeveld, F. J. M. (2009) · Journal of Virology · doi:10.1128/jvi.01244-09 · Cited by 179 · see citing works

Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Cunningham, M. W., Antone, S. M., Gulizia, J. M., McManus, B. M., Fischetti, V. A., & Gauntt, C. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1320 · Cited by 176 · see citing works

The group B coxsackieviruses and myocarditis

Kim, K., Hufnagel, G., Chapman, N. M., & Tracy, S. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.326 · Cited by 174 · see citing works

Caspase Activation and Specific Cleavage of Substrates after Coxsackievirus B3-Induced Cytopathic Effect in HeLa Cells

Carthy, C. M., Granville, D. J., Watson, K. A., Anderson, D. R., Wilson, J. E., Yang, D., Hunt, D. W. C., & McManus, B. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7669-7675.1998 · Cited by 172 · see citing works

Expression of the Primary Coxsackie and Adenovirus Receptor Is Downregulated during Skeletal Muscle Maturation and Limits the Efficacy of Adenovirus-Mediated Gene Delivery to Muscle Cells

Nalbantoglu, J. N., Pari, G., Karpati, G., & Holland, P. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950018409 · Cited by 169 · see citing works

Protective Role for Interferon-β in Coxsackievirus B3 Infection

Deonarain, R., Cerullo, D., Fuse, K., Liu, P. P., & Fish, E. N. (2004) · Circulation · doi:10.1161/01.cir.0000136824.73458.20 · Cited by 160 · see citing works

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

Kandolf, R., Canu, A., & Hofschneider, P. H. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(85)80019-5 · Cited by 136 · see citing works

Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development

Dorner, A. A., Wegmann, F., Butz, S., Wolburg‐Buchholz, K., Wolburg, H., Mack, A. F., Nasdala, I., August, B. K., Westermann, J., Rathjen, F. G., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.02476 · Cited by 128 · see citing works

Treatment of picornavirus infections

Rotbart, H. A. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00206-6 · Cited by 110 · see citing works

Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway

Si, X., McManus, B. M., Zhang, J., Ji, Y., Cheung, C., Esfandiarei, M., Suarez, A., Morgan, A., & Luo, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8014-8023.2005 · Cited by 110 · see citing works

Fluoxetine is a potent inhibitor of coxsackievirus replication

Zuo, J., Quinn, K. K., Kye, S., Cooper, P., Damoiseaux, R., & Krogstad, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00983-12 · Cited by 104 · see citing works

Generation of Human iPSCs from Human Peripheral Blood Mononuclear Cells Using Non-integrative Sendai Virus in Chemically Defined Conditions

Churko, J. M., Burridge, P. W., & Wu, J. C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-511-8_7 · Cited by 95 · see citing works

Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development

Asher, D. R., Cerny, A., Weiler, S. R., Horner, J. W., Keeler, M. L., Neptune, M. A., Jones, S. N., Bronson, R. T., DePinho, R. A., & Finberg, R. W. (2005) · genesis · doi:10.1002/gene.20127 · Cited by 92 · see citing works

Induction of Coxsackievirus-Adenovirus–Receptor Expression During Myocardial Tissue Formation and Remodeling

Fechner, H., Noutsias, M., Tschöepe, C., Hinze, K., Wang, X., Escher, F., Pauschinger, M., Dekkers, D. H. W., Vetter, R., Paul, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000050150.27478.c5 · Cited by 92 · see citing works

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.

Saraste, A., Arola, A., Vuorinen, T., Kytö, V., Kallajoki, M., Pulkki, K., Voipio-Pulkki, L., & Hyypiä, T. (2003) · Cardiovascular pathology · doi:10.1016/s1054-8807(03)00077-2 · Cited by 90 · see citing works

CVB Infection and Mechanisms of Viral Cardiomyopathy

Knowlton, K. U. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_15 · Cited by 82 · see citing works

PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells

Lanke, K. H. W., Krenn, B. M., Melchers, W. J. G., Seipelt, J., & van Kuppeveld, F. J. M. (2007) · Journal of General Virology · doi:10.1099/vir.0.82634-0 · Cited by 72 · see citing works

Virus-Host Coevolution in a Persistently Coxsackievirus B3-Infected Cardiomyocyte Cell Line

Pinkert, S., Klingel, K., Lindig, V., Dörner, A., Zeichhardt, H., Spiller, O. B., & Fechner, H. (2011) · Journal of Virology · doi:10.1128/jvi.00621-11 · Cited by 58 · see citing works

Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies

Lombardi, R., Bell, A., Senthil, V., Sidhu, J. S., Noseda, M., Roberts, R., & Marian, A. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn078 · Cited by 57 · see citing works

Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat

Kashimura, T., Kodama, M., Hotta, Y., Hosoya, J., Yoshida, K., Ozawa, T., Watanabe, R., Okura, Y., Kato, K., Hanawa, H., et al. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0925-9 · Cited by 52 · see citing works

Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy

Graudins, A., Vossler, C., & Wang, R. T. (1997) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(97)90194-7 · Cited by 42 · see citing works

Patient-Specific Stem Cells and Cardiovascular Drug Discovery

Mordwinkin, N. M., Lee, A. S., & Wu, J. C. (2013) · JAMA · doi:10.1001/jama.2013.282409 · Cited by 40 · see citing works

Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-α

Heim, A., Grumbach, I. M., Pring‐Åkerblom, P., Stille‐Siegener, M., Müller, G., Kandolf, R., & Figulla, H. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)01028-0 · Cited by 34 · see citing works

Human embryonic stem cells and derived contractile embryoid bodies are susceptible to Coxsakievirus B infection and respond to interferon Iβ treatment

Scassa, M. É., de Giusti, C. J., Questa, M., Prêtre, G., Videla-Richardson, G. A., Blüguermann, C., Romorini, L., Ferrer, M. F., Sevlever, G. E., Miriuka, S., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.09.002 · Cited by 22 · see citing works

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217 · see citing works

Viral myocarditis—diagnosis, treatment options, and current controversies

Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657 · see citing works

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

Sharma, A., Burridge, P. W., McKeithan, W. L., Serrano, R., Shukla, P., Sayed, N., Churko, J. M., Kitani, T., Wu, H., Holmström, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2584 · Cited by 404 · see citing works

Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection

Sharma, A., Garcia, G., Wang, Y., Plummer, J., Morizono, K., Arumugaswami, V., & Svendsen, C. N. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100052 · Cited by 318 · see citing works

RNA–protein interaction detection in living cells

Ramanathan, M., Majzoub, K., Rao, D. S., Neela, P. H., Zarnegar, B. J., Mondal, S., Roth, J. G., Gai, H., Kovalski, J. R., Siprashvili, Z., et al. (2018) · Nature Methods · doi:10.1038/nmeth.4601 · Cited by 301 · see citing works

Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform

Denning, C., Borgdorff, V., Crutchley, J., Firth, K. S. A., George, V., Kalra, S., Kondrashov, A., Hoang, M. D., Mosqueira, D., Patel, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.014 · Cited by 293 · see citing works

Translation of Human iPSCs: From Clinical Trial in a Dish to Precision Medicine

Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 263 · see citing works

Induced Pluripotent Stem Cells 10 Years Later

Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 266 · see citing works

Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association

Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 230 · see citing works

Cardiovascular disease models: A game changing paradigm in drug discovery and screening

Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223 · see citing works

Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer

Kitani, T., Ong, S.-G., Lam, C. K., Rhee, J.-W., Zhang, J. Z., Oikonomopoulos, A., Ma, N., Tian, L., Lee, J., Telli, M. L., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037357 · Cited by 200 · see citing works

Induced pluripotent stem cells: at the heart of cardiovascular precision medicine

Chen, I. Y., Matsa, E., & Wu, J. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.36 · Cited by 191 · see citing works

Electroconductive Biohybrid Hydrogel for Enhanced Maturation and Beating Properties of Engineered Cardiac Tissues

Roshanbinfar, K., Vogt, L., Greber, B., Diecke, S., Boccaccini, A. R., Scheibel, T., & Engel, F. B. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201803951 · Cited by 193 · see citing works

Matrigel Mattress

Feaster, T. K., Cadar, A. G., Wang, L., Williams, C. H., Chun, Y. W., Hempel, J. E., Bloodworth, N. C., Merryman, W. D., Lim, C. C., Wu, J. C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.307580 · Cited by 178 · see citing works

Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories

Hwang, H. S., Kryshtal, D. O., Feaster, T. K., Sánchez-Freire, V., Zhang, J., Kamp, T. J., Hong, C. C., Wu, J. C., & Knollmann, B. C. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.003 · Cited by 173 · see citing works

Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes

Yücel, G., Zhao, Z., El‐Battrawy, I., Lan, H., Lang, S., Li, X., Buljubasic, F., Zimmermann, W., Cyganek, L., Utikal, J. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03147-4 · Cited by 163 · see citing works

Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening

Smith, A. S. T., Macadangdang, J., Leung, W., Laflamme, M., & Kim, D.-H. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 137 · see citing works

Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity

Sharma, A., McKeithan, W. L., Serrano, R., Kitani, T., Burridge, P. W., del Álamo, J. C., Mercola, M. A., & Wu, J. C. (2018) · Nature Protocols · doi:10.1038/s41596-018-0076-8 · Cited by 141 · see citing works

TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1

Lu, Y., Hu, Y., Wu, Z., Li, Y., Kong, M., Kang, Z., Zuoyuan, B., & Yang, Z. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05027-w · Cited by 133 · see citing works

Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart

Song, M., & Dorn, G. W. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.019 · Cited by 127 · see citing works

Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis

Belkaya, S., Kontorovich, A., Byun, M., Mulero‐Navarro, S., Bajolle, F., Cobat, A., Josowitz, R., Itan, Y., Quint, R., Lorenzo, L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.043 · Cited by 132 · see citing works

Carbon nanotube doped pericardial matrix derived electroconductive biohybrid hydrogel for cardiac tissue engineering

Roshanbinfar, K., Mohammadi, Z., Mesgar, A. S.-M., Dehghan, M. M., Oommen, O. P., Hilborn, J. G., & Engel, F. B. (2019) · Biomaterials Science · doi:10.1039/c9bm00434c · Cited by 115 · see citing works

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Sharma, A., Li, G., Rajarajan, K., Hamaguchi, R., Burridge, P. W., & Wu, S. M. (2015) · Journal of Visualized Experiments · doi:10.3791/52628 · Cited by 110 · see citing works

Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis

Sin, J., Mangale, V., Thienphrapa, W., Gottlieb, R. A., & Feuer, R. (2015) · Virology · doi:10.1016/j.virol.2015.06.006 · Cited by 106 · see citing works

Human induced pluripotent stem cells as a platform for personalized and precision cardiovascular medicine

Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105 · see citing works

Antitumor/antiviral carbon quantum dots based on carrageenan and pullulan

Emam, H. E., & Ahmed, H. B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.151 · Cited by 102 · see citing works

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

Ergir, E., Oliver-De La Cruz, J., Fernandes, S., Cassani, M., Niro, F., Pereira-Sousa, D., Vrbský, J., Vinarský, V., Perestrelo, A. R., Debellis, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22225-w · Cited by 99 · see citing works

Native cardiac environment and its impact on engineering cardiac tissue

Schwach, V., & Passier, R. C. (2019) · Biomaterials Science · doi:10.1039/c8bm01348a · Cited by 92 · see citing works

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart

van der Velden, J., Asselbergs, F. W., Bakkers, J., Batkai, S., Bertrand, L., Bezzina, C. R., Bot, I., Brundel, B. J. J. M., Carrier, L., Chamuleau, S. A. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab370 · Cited by 88 · see citing works

Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes

Choi, S. W., Shin, J. S., Park, S., Jung, E., Park, Y.-G., Lee, J., Kim, S. J., Park, H., Lee, J., Park, S., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104955 · Cited by 83 · see citing works

Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates

Cheng, Y., Hsieh, M. L., Lin, C., Chang, C. M., Huang, C.-Y., Puntney, R., Moy, A., Ting, C.-Y., Chan, D. Z. H., Nicholson, M. W., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061736 · Cited by 77 · see citing works

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies

Brodehl, A., Ebbinghaus, H., Deutsch, M., Gummert, J., Gärtner, A., Ratnavadivel, S., & Milting, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184381 · Cited by 58 · see citing works

Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions

Findley, A. S., Monziani, A., Richards, A. L., Rhodes, K., Ward, M. C., Kalita, C. A., Alazizi, A., Pazokitoroudi, A., Sankararaman, S., Wen, X., et al. (2021) · eLife · doi:10.7554/elife.67077 · Cited by 66 · see citing works

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential

van Mil, A., Balk, G. M., Neef, K., Buikema, J. W., Asselbergs, F. W., Wu, S. M., Doevendans, P. A., & Sluijter, J. P. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy208 · Cited by 65 · see citing works

Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes

Shen, J., Wang, X., Zhou, D., Li, T., Tang, L. F. P., Gong, T., Su, J., & Liang, P. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13702 · Cited by 54 · see citing works

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53

Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 52 · see citing works

Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?

Ebert, A., Diecke, S., Chen, I. Y., & Wu, J. C. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201504395 · Cited by 52 · see citing works

In SilicoPharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers

Cai, C., Fang, J., Guo, P., Wang, Q., Hong, H., Moslehi, J. J., & Cheng, F. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00641 · Cited by 52 · see citing works

Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue

Lock, R. I., Graney, P. L., Tavakol, D. N., Nash, T. R., Kim, Y., Sanchez, E., Morsink, M. A. J., Ning, D., Chen, C., Fleischer, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114302 · Cited by 48 · see citing works

Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes

Burridge, P. W., Diecke, S., Matsa, E., Sharma, A., Wu, H., & Wu, J. C. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_196 · Cited by 47 · see citing works

Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects

Samak, M., & Hinkel, R. (2019) · Cells · doi:10.3390/cells8121530 · Cited by 45 · see citing works

Clinical Trials in a Dish

Strauss, D. G., & Blinova, K. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.009 · Cited by 42 · see citing works

Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation

Sharma, A., Zhang, Y., Buikema, J. W., Serpooshan, V., Chirikian, O., Kosaric, N., Churko, J. M., Dzilic, E., Shieh, A., Burridge, P. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24954-3 · Cited by 41 · see citing works

In-vivo wound healing activity of a novel composite sponge loaded with mucilage and lipoidal matter of Hibiscus species

Bakr, R. O., Amer, R. I., Attia, D. A., Abdelhafez, M. M., Al‐Mokaddem, A. K., El‐Gendy, A. E. G., El-Fishawy, A. M., Fayed, M. A. A., & Gad, S. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111225 · Cited by 41 · see citing works

Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation

Tang, X., Wang, Z., Hu, S., & Zhou, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071313 · Cited by 40 · see citing works

Differentiation and Contractile Analysis of GFP‐Sarcomere Reporter hiPSC‐Cardiomyocytes

Sharma, A., Toepfer, C. N., Schmid, M., Garfinkel, A. C., & Seidman, C. E. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.53 · Cited by 38 · see citing works

Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection

Bozzi, A., Sayed, N., Matsa, E., Sass, G., Neofytou, E. A., Clemons, K. V., Corrêa‐Oliveira, R., Stevens, D. A., & Wu, J. C. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.017 · Cited by 37 · see citing works

Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells

Mozneb, M., Jenkins, A., Sances, S., Pohlman, S., Workman, M. J., West, D., Ondatje, B. N., El‐Ghazawi, K., Woodbury, A., Garcia, V. J., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00745f · Cited by 36 · see citing works

Clinical Trial in a Dish

Lam, C. K., & Wu, J. C. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314695 · Cited by 37 · see citing works

In vitro model of ischemic heart failure using human induced pluripotent stem cell–derived cardiomyocytes

Davis, J. A., Chouman, A., Creech, J., da Rocha, A. M., Ponce‐Balbuena, D., Jiménez‐Vázquez, E. N., Nichols, R., Lozhkin, A. P., Madamanchi, N. R., Campbell, K. F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.134368 · Cited by 36 · see citing works

Innate and adaptive immunity in acute myocarditis

Golino, M., Harding, D., Buono, M. G. D., Fanti, S., MOHIDDIN, S. A., Toldo, S. A., Smyth, J. W., Sanna, T., Marelli‐Berg, F. M., & Abbate, A. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.131901 · Cited by 38 · see citing works

Metabolite Profiling of Aquilaria malaccensis Leaf Extract Using Liquid Chromatography-Q-TOF-Mass Spectrometry and Investigation of Its Potential Antilipoxygenase Activity In-Vitro

Eissa, M., Hashim, Y. Z. H.-Y., El‐Kersh, D. M., Azziz, S. S. S. A., Salleh, H. M., Isa, M., & Warif, N. M. A. (2020) · Processes · doi:10.3390/pr8020202 · Cited by 35 · see citing works

Machine learning identifies abnormal Ca2+ transients in human induced pluripotent stem cell-derived cardiomyocytes

Hwang, H., Liu, R., Maxwell, J. T., Yang, J., & Xu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73801-x · Cited by 35 · see citing works

Luteolin inhibits CVB3 replication through inhibiting inflammation

Wu, S., Wang, H., Guo, T., & Li, Y. (2019) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2019.1642329 · Cited by 34 · see citing works

Anticancer and microbicide action of carbon quantum dots derived from microcrystalline cellulose: Hydrothermal versus infrared assisted techniques

Mogharbel, A. T., Abu‐Melha, S., Hameed, A. M., Attar, R. M. S., Alrefaei, A. F., Almahri, A., & El‐Metwaly, N. M. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104419 · Cited by 34 · see citing works

TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes

Sattler, K., El‐Battrawy, I., Cyganek, L., Lang, S., Lan, H., Li, X., Zhao, Z., Utikal, J. S., Wieland, T., Borggrefe, M. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93958-3 · Cited by 31 · see citing works

Chitosan Schiff bases-based polyelectrolyte complexes with graphene quantum dots and their prospective biomedical applications

Hamed, A. A., Saad, G. R., Abdelhamid, I. A., Elwahy, A. H. M., Abdel‐Aziz, M. M., & Elsabee, M. Z. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.199 · Cited by 31 · see citing works

Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice

Jiang, Y., Zhu, Y., Mu, Q., Luo, H., Zhi, Y., & Shen, X. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.01.013 · Cited by 31 · see citing works

Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems

Trevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015) · Viruses · doi:10.3390/v7072800 · Cited by 28 · see citing works

A new era of disease modeling and drug discovery using induced pluripotent stem cells

Suh, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0871-0 · Cited by 29 · see citing works

Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non‐Integrating Viral Reprogramming Vector

Sharma, A., Mücke, M. B., & Seidman, C. E. (2018) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.58 · Cited by 27 · see citing works

CHIR99021 Promotes hiPSC‐Derived Cardiomyocyte Proliferation in Engineered 3D Microtissues

Hesselbarth, R., Esser, T. U., Roshanbinfar, K., Schrüfer, S., Schubert, D. W., & Engel, F. B. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100926 · Cited by 26 · see citing works

Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery

Zhu, K., Bao, X., Wang, Y., Lu, T., & Zhang, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113970 · Cited by 26 · see citing works

Biodegradable suture development-based albumin composites for tissue engineering applications

Naser, M. A., Sayed, A. M., Abdelmoez, W., El-Wakad, M. T., & Abdo, M. S. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-58194-5 · Cited by 25 · see citing works

Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function

Calhoun, P. J., Phan, A. V., Taylor, J. D., James, C. C., Padget, R. L., Zeitz, M. J., & Smyth, J. W. (2020) · The FASEB Journal · doi:10.1096/fj.202000667r · Cited by 25 · see citing works

Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine

Sharma, A., Zhang, Y., & Wu, S. M. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0404-z · Cited by 25 · see citing works

Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease

Lara, L. D. S., de Andrade-Lima, L. C., Calvet, C. M., Borsoi, J., Duque, T. L. A., Henriques‐Pons, A., Pereira, M. C. D. S., & Pereira, L. V. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.03.002 · Cited by 25 · see citing works

Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs

Guo, H., Liu, L., Nishiga, M., Cong, L., & Wu, J. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.009 · Cited by 27 · see citing works

Cardiac regeneration: Options for repairing the injured heart

Wang, J., An, M., Haubner, B. J., & Penninger, J. M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.981982 · Cited by 24 · see citing works

Dilated Cardiomyopathy

Knowlton, K. U. (2019) · Circulation · doi:10.1161/circulationaha.119.040037 · Cited by 23 · see citing works

Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Bezzerides, V. J., Zhang, D., & Pu, W. T. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-1113 · Cited by 23 · see citing works

Application of Human Induced Pluripotent Stem Cell-Derived Cellular and Organoid Models for COVID-19 Research

Luo, Y., Zhang, M., Chen, Y., Chen, Y., & Zhu, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720099 · Cited by 22 · see citing works

Inhaled Atorvastatin Nanoparticles for Lung Cancer

Tulbah, A. S. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220426091500 · Cited by 22 · see citing works

Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications

Wong, C., Lam, T.-H., Liao, S.-Y., Lau, Y., Tse, H., & So, B. Y. F. (2023) · Biomedicines · doi:10.3390/biomedicines11010107 · Cited by 21 · see citing works

Fucoidan-Based Gold Nanoparticles: Antioxidant and Anticancer Potential from Turbinaria decurrens and Sargassum cinereum

Newehy, A. S. E., Gheda, S. F., Ismail, M. M., Aldisi, D. A., Abulmeaty, M. M. A., & Elshobary, M. E. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070826 · Cited by 20 · see citing works

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Fonoudi, H., Ansari, H., Abbasalizadeh, S., Blue, G. M., Aghdami, N., Winlaw, D. S., Harvey, R. P., Bosman, A., & Baharvand, H. (2016) · Journal of Visualized Experiments · doi:10.3791/54276 · Cited by 20 · see citing works

Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease

Atmanli, A., & Domian, I. J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.010 · Cited by 19 · see citing works

Assessment of human bioengineered cardiac tissue function in hypoxic and re-oxygenized environments to understand functional recovery in heart failure

Yamasaki, Y., Matsuura, K., Sasaki, D., & Shimizu, T. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.03.007 · Cited by 19 · see citing works

Myocarditis

Knowlton, K. U. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.008 · Cited by 19 · see citing works

Lack in Treatment Options for Virus-Induced Inflammatory Cardiomyopathy

Linthout, S. V., Tschöpe, C., & Schultheiß, H. (2014) · Circulation Research · doi:10.1161/circresaha.114.304951 · Cited by 18 · see citing works

MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?

White, M. C., Pang, L., & Yang, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.05.025 · Cited by 17 · see citing works

Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies

Kalra, R. S., Dhanjal, J. K., Das, M., Singh, B., & Naithani, R. (2021) · Cells · doi:10.3390/cells10102558 · Cited by 17 · see citing works

Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective

Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 17 · see citing works

Optimization and characterization of antileukemic l-asparaginase produced by Fusarium solani endophyte

Osama, S., El-Sherei, M. M., Al-Mahdy, D. A., Bishr, M. M., Salama, O., & Raafat, M. M. (2023) · AMB Express · doi:10.1186/s13568-023-01602-2 · Cited by 17 · see citing works

Cardiomyopathy: pathogenesis and therapeutic interventions

Huang, S., Li, J., Li, Q., Wang, Q., Zhou, X., Chen, J., Chen, X., Bellou, A., Zhuang, J., & Lei, L. (2024) · MedComm · doi:10.1002/mco2.772 · Cited by 17 · see citing works

Biophysicochemical studies of a ruthenium (II) nitrosyl thioether‐thiolate complex binding to BSA: Mechanistic information, molecular docking, and relationship to antibacterial and cytotoxic activities

Shereef, H. A., Shaban, S. Y., Moemen, Y. S., El‐Khouly, M. E., & El‐Nahas, A. M. (2022) · Applied Organometallic Chemistry · doi:10.1002/aoc.6583 · Cited by 16 · see citing works

Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells

Rockwood, S. J., Arzt, M., & Sharma, A. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01813-2 · Cited by 15 · see citing works

The first versatile human iPSC-based model of ectopic virus induction allows new insights in RNA-virus disease

Peischard, S., Ho, H. T., Piccini, I., Strutz‐Seebohm, N., Röpke, A., Liashkovich, I., Gosain, H., Rieger, B., Klingel, K., Eggers, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72966-9 · Cited by 15 · see citing works

Pluripotent Stem Cell-Derived Hepatocyte-like Cells: A Tool to Study Infectious Disease

Schwartz, R. E., Bram, Y., & Frankel, A. S. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0113-7 · Cited by 15 · see citing works

Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells

Sakurai, F., Kunito, T., Takayama, K., Hashimoto, R., Tachibana, M., Sakamoto, N., Wakita, T., & Mizuguchi, H. (2017) · Virus Research · doi:10.1016/j.virusres.2017.09.004 · Cited by 15 · see citing works

Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity

Pinheiro, E. A., Magdy, T., & Burridge, P. W. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09962-x · Cited by 15 · see citing works

Biochemical Profile and In Vitro Therapeutic Properties of Two Euhalophytes, Halocnemum strobilaceum Pall. and Suaeda fruticosa (L.) Forske., Grown in the Sabkha Ecosystem in the Algerian Sahara

Gheraissa, N., Chemsa, A. E., Cherrada, N., Erol, E., Elsharkawy, E. R., Amara, D. G., Zeghoud, S., Rebiai, A., Messaoudi, M., SAWICKA, B. H., et al. (2023) · Molecules · doi:10.3390/molecules28083580 · Cited by 14 · see citing works

Erbium oxide nanoparticles induce potent cell death, genomic instability and ROS-mitochondrial dysfunction-mediated apoptosis in U937 lymphoma cells

Mohamed, H. R. H., Elberry, Y. A., Magdy, H., Ismail, M., Michael, M., Eltayeb, N., & Safwat, G. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03962-x · Cited by 13 · see citing works

In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell® Cardiomyocytes

Kraft, L., Sauter, M., Seebohm, G., & Klingel, K. (2021) · Viruses · doi:10.3390/v13091835 · Cited by 13 · see citing works

Lactate- and immunomagnetic-purified hiPSC–derived cardiomyocytes generate comparable engineered cardiac tissue constructs

Rossler, K. J., de Lange, W. J., Mann, M. W., Aballo, T. J., Melby, J. A., Zhang, J., Kim, G., Bayne, E. F., Zhu, Y., Farrell, E. T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.172168 · Cited by 12 · see citing works

Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency

Kamal, N. H., Saber, F. R., Salama, A., Abouhussein, D. M. N., Ismail, S., El-Hefnawy, H. M., & Meselhy, M. R. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00678-2 · Cited by 12 · see citing works

Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference

Povsic, T. J., Scott, R. C., Mahaffey, K. W., Blaustein, R. O., Edelberg, J. M., Lefkowitz, M. P., Solomon, S. D., Fox, J. C., Healy, K. E., Khakoo, A. Y., et al. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6739-9 · Cited by 12 · see citing works

Investigating pediatric disorders with induced pluripotent stem cells

Durbin, M. D., Cadar, A. G., Chun, Y. W., & Hong, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0064-2 · Cited by 11 · see citing works

Synthesis, characterization, and bioactivity evaluation of several divalent transition metal ion-bioflavonoid complexes

Mohsen, E. M. A., Saeed, A. A. M., & Yahia, A.-R. A. B. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101535 · Cited by 10 · see citing works

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease

Bosman, A., Edel, M. J., Blue, G. M., Dilley, R. J., Harvey, R. P., & Winlaw, D. S. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4040768 · Cited by 10 · see citing works

A Genetically Modified, Enterovirus-Based Expression System in Human Induced Pluripotent Stem Cells for the Safe Study of Viral Pathomechanisms

Seebohm, G., Strutz‐Seebohm, N., Hescheler, J., & Peischard, S. (2025) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170476

A new hiPSC-based viral expression system to study virus host-cell interaction in hiPSC-derived cardiomyocytes

Peischard, S., Strutz‐Seebohm, N., & Seebohm, G. (2024) · EP Europace · doi:10.1093/europace/euae102.613

In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell® Cardiomyocytes

Kraft, L., Sauter, M., Seebohm, G., & Klingel, K. (2021) · Viruses · doi:10.3390/v13091835 · Cited by 13 · see citing works

Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury

Wong, C., Luk, H. K. H., Lai, W., Lau, Y., Zhang, R., Wong, A. C. P., Lo, G. C.-S., Chan, K., Hung, I. F., Tse, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0881 · Cited by 46 · see citing works

Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis

Miteva, K., Haag, M., Peng, J., Savvatis, K., Becher, P. M., Seifert, M., Warstat, K., Westermann, D., Ringe, J., Sittinger, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028513 · Cited by 40 · see citing works